Cyproheptadine hydrochloride
Brand names: Periactin
Cyproheptadine is a first-generation, sedating antihistamine with additional antiserotonergic activity, used for allergic conditions and pruritus and sometimes for migraine prophylaxis or appetite stimulation.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It antagonises histamine H1 receptors and serotonin (5-HT) receptors, producing antihistamine, antipruritic, appetite-stimulating and antimigraine effects.
Prescribing in practice
- It is markedly sedating with antimuscarinic effects, so avoid in narrow-angle glaucoma, urinary retention and prostatic enlargement, and use caution in the elderly because of confusion and falls.
- Additive sedation and antimuscarinic burden occur with alcohol, other antihistamines, tricyclics and anticholinergics.
- Its appetite-stimulant and weight-gain effect can be useful in selected patients but is undesirable in others.
Monitoring
Routine laboratory monitoring is not required; review for sedation, anticholinergic effects and, where relevant, weight change.
Counselling the patient
- Expect drowsiness and avoid driving or operating machinery until you know how it affects you.
- Avoid alcohol while taking it.
- Report difficulty passing urine, dry mouth or blurred vision.
Evidence & guidelines
Cyproheptadine is a long-established antihistamine whose sedative and antiserotonergic properties underpin its varied uses.
Reference: TOXBASE / NPIS serotonin syndrome; SmPC; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Sepsis Screening and Sepsis Six · UK Sepsis Trust; NICE NG51; Surviving Sepsis Campaign 2021
- Unintentional Weight Loss Workup · NICE NG12; BSG
- Chronic Fatigue Workup · NICE NG206; BMJ Best Practice
- Lymphadenopathy Workup · NICE NG12; BMJ Best Practice
- Pre-op Medical Clearance · NICE NG45; ESC 2022
- Secondary Hypertension Workup · NICE NG136; ESH 2023